1
EXHIBIT 99.1
Amedisys
===============================================================================
Amedisys
A Healthy Investment for The 21st Century
===============================================================================
Statements contained in this presentation which are not historical facts are
forward-looking statements. These forward-looking statements and all other
statements that may be contained in this presentation that are not historical
facts are subject to a number of risks and uncertainties, and actual results may
differ materially than those forecasted. Such forward-looking statements are
estimates reflecting the best judgment of Amedisys, Inc. management based upon
currently available information. Certain factors which could affect the accuracy
of such forward-looking statements are identified in the public filings made by
Amedisys, Inc. with the Securities and Exchange Commission, and forward-looking
statements contained herein, or other public statements of Amedisys, Inc. or its
management should be considered in light of those factors.
===============================================================================
Amedisys Facts
o One of the top 5 U.S. home nursing companies
o Doubled in size with Columbia acquisition
o 50 locations in the South with comprehensive services
o Skilled nursing care supported with acute care technology
o Publicly traded since 1994
===============================================================================
Home Health Care Facts
1800's Home Health Care Began October 1, 2000 Medicare allows profits
1965 Medicare started coverage 1999 Industry consolidation/closures
Home Health Care
1980's Technology goes to the home 1999 $36 Billion industry
1997 Balanced Budget Act changed 1999 20,000 Providers treated
the rules 8M people
===============================================================================
What is Home Health Care Today?
"Medical care delivered to a homebound patient by licensed professionals
supervised by the patient's physician."
============================================================================
2
What Does Amedisys Offer?
Care in These Areas...
Diabetes Cardiac Orthopedics
Cancer Respiratory Neurology
Wound Care Post-Surgical
Antibiotic Therapy Rehabilitation
Pain Mgt. Hydration Malnutrition
============================================================================
Why Is Amedisys a Healthy Investment?
o AMED positioned in a growing market
o AMED provides low cost alternative care
o AMED is profitable
o AMED is partnered with industry leaders
============================================================================
Amedisys Positioned in a Growing Market
Pop. 65 yrs. and over. US, 1950 - 2030
1950 1960 1970 1980 1990 2000 2010 2020 2030
85+ 0.6 0.9 1.5 2.2 3.0 4.3 5.7 6.5 8.5
65+ 12.2 16.6 20.1 25.5 31.1 34.7 39.4 53.2 69.4
Source: Health, U.S. 1999, Health and Aging
Chartbook, U.S. Health and Human Services Dept.
Current patients per 1,000 Population
Women Men
65-74 yrs. 27.6 18.2
75-84 yrs. 84.1 55.4
85+ 130.1 99.5
============================================================================
3
Amedisys Positioned in a Growing Market
Home Health Services Received By
Patients 65 Years of Age and Over
Nursing 85.3%
Homemaker 28.7%
Physical therapy 20.0%
Social services 10.9%
Medications 9.9%
Continuous home care 5.8%
Occupational therapy 4.8%
MC services 3.7%
Nutrition 3.4%
Other services 15.1%
Source: Health, U.S. 1999, Health and Aging
Chartbook, U.S. Health and Human Services Dept.
============================================================================
Amedisys Positioned in the Largest Industry Segment...
Nursing 70% STOCK PRICES
Infusion 14% 3-30-01
Respiratory 10% NURSING
DME 6% Amedisys $6.38
Gentiva $19.06
RESPIRATORY
Lincare $52.94
INFUSION
Apria $24.18
============================================================================
Amedisys Provides Low Cost Alternative Care
o Home care reduces length of hospital stays
o Provides an alternative to hospitalization
o Millimann & Robertson - avoidable inpatient care is 56 - 64%
o Patients prefer home care
============================================================================
4
Amedisys is Profitable
Historical Perspective
REVENUES 2000 1999 1998 1997
Amounts in Restated Restated
Millions except
Per share data
NET SERVICE REVENUE $90.8 $97.4 $ 25.5 $25.8
NET INCOME $ 6.4 $ 1.3 $(28.9) $(1.2)
EARNINGS $1.47 $ .42 $(8.12) $(.43)
PER SHARE
============================================================================
Amedisys is Profitable
Major Cost Reduction Initiative
o Restructured Columbia debt with a gain of $6.5M
o Lowered costs under Medicare episode payment
o Reduced offices from 100 to 50, increased patients by 10%
o Cut $15M from cost of operations
o Brought corporate staff from 200 to 67
o Reduced costs of nursing visit by 30%
============================================================================
Amedisys is Profitable
Prospective Payment System
Example: Patient with Diabetes
Fixed Rate $2,115
Illness Adj. 740
Wage Index (63)
Total Payment Per Episode $2,792
Net Profit $300
============================================================================
Amedisys is Profitable
Amedisys, Inc. - 4th Quarter 2000
Average Revenue Cost of Revenue Gross Margin
Per Episode Per Episode Per Episode
Alabama $2,550 $ 938 $1,612
Georgia $2,387 $ 955 $1,432
North Carolina $2,209 $ 947 $1,262
Oklahoma $2,336 $ 792 $1,544
Louisiana $2,357 $ 942 $1,415
Tennessee $2,281 $ 964 $1,317
Florida $2,237 $1,061 $1,176
TOTAL COMPANY $2,377 $ 951 $1,426
============================================================================
5
Amedisys is Profitable
o Reduced direct costs, increased gross margin
o Reduced indirect costs, lowered breakeven point
o Re-allocated resources from admin. to frontline
o Frontline clinical managers adhere to protocols for consistent care
o Frontline sales force surpasses the competition
o Acquisitions available at low costs
============================================================================
Amedisys is Partnered with Industry Leaders
ConvaTec
A Bristol-Myers Squibb Company
Hill-Rom Mead Johnson
A HILLENBRAND INDUSTRY Nutritionals
DU PONT
DuPont Pharmaceutical Company
============================================================================
Amedisys is a Healthy Investment...
Positioned in a Growing Market
Provides Low Cost Alternative Care
Positioned for Profitability
Partnered with Industry Leaders
Hill-Rom
A HILLENBRAND INDUSTRY
ConvaTec
A Bristol Myers Squibb Company
Mead Johnson
Nutritionals
DU PONT
DuPont Pharmaceuticals Company
============================================================================
Put Amedisys in Your Portfolio
Amedisys, Inc.
The Healthy Investment for the 21st Century